The role of estrogens in male skeletal development

被引:8
作者
Bilezikian, JP
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA
关键词
D O I
10.1071/RD00120
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The developing human skeleton is known to be influenced by the presence of sex steroids. In girls, estrogens have been considered to be the dominant hormone, whereas in boys, androgens have occupied a primary physiological role in terms of bone mass accrual. Although these views are still current, recent observations made of rare defects in estrogen receptor sensitivity or estrogen synthesis have called attention to the importance of estrogens in the developing male skeleton. In these human genetic models, the affected men have demonstrated continuous linear skeletal growth, open epiphyses, lack of pubertal growth spurt, and reduced bone mass. In the example of men with aromatase deficiency, lacking estrogens from birth, administration of estrogen led to impressive increases in bone density, maturation of the skeletal growth plates, and cessation of linear growth. Animal models mimicking these human syndromes by knockout technology, have tended to support these observations. The data argue for a primary role of estrogens in the developing male skeleton, while not diminishing the important role for androgens.
引用
收藏
页码:253 / 259
页数:7
相关论文
共 36 条
[1]  
[Anonymous], WILLIAMS TXB ENDOCRI
[2]   SEX-DIFFERENCES IN GEOMETRY OF THE FEMORAL-NECK WITH AGING - A STRUCTURAL-ANALYSIS OF BONE-MINERAL DATA [J].
BECK, TJ ;
RUFF, CB ;
SCOTT, WW ;
PLATO, CC ;
TOBIN, JD ;
QUAN, CA .
CALCIFIED TISSUE INTERNATIONAL, 1992, 50 (01) :24-29
[3]   Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty [J].
Bertelloni, S ;
Baroncelli, GI ;
Ferdeghini, M ;
Perri, G ;
Saggese, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (12) :4280-4283
[4]   Osteoporosis in men [J].
Bilezikian, JP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3431-3434
[5]   Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency [J].
Bilezikian, JP ;
Morishima, A ;
Bell, J ;
Grumbach, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :599-603
[6]  
Bulun SE, 1997, J STEROID BIOCHEM, V61, P133
[7]   USE OF TISSUE-SPECIFIC PROMOTERS IN THE REGULATION OF AROMATASE CYTOCHROME-P450 GENE-EXPRESSION IN HUMAN TESTICULAR AND OVARIAN SEX CORD TUMORS, AS WELL AS IN NORMAL FETAL AND ADULT GONADS [J].
BULUN, SE ;
ROSENTHAL, IM ;
BRODIE, AMH ;
INKSTER, SE ;
ZELLER, WP ;
DIGEORGE, AM ;
FRASIER, SD ;
KILGORE, MW ;
SIMPSON, AER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1616-1621
[8]   Effect of testosterone and estradiol in a man with aromatase deficiency [J].
Carani, C ;
Qin, K ;
Simoni, M ;
FaustiniFustini, M ;
Serpente, S ;
Boyd, J ;
Korach, KS ;
Simpson, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (02) :91-95
[9]   AN AROMATASE-PRODUCING SEX-CORD TUMOR RESULTING IN PREPUBERTAL GYNECOMASTIA [J].
COEN, P ;
KULIN, H ;
BALLANTINE, T ;
ZAINO, R ;
FRAUENHOFFER, E ;
BOAL, D ;
INKSTER, S ;
BRODIE, A ;
SANTEN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (05) :317-322
[10]   Estrogen receptor null mice: What have we learned and where will they lead us? [J].
Couse, JF ;
Korach, KS .
ENDOCRINE REVIEWS, 1999, 20 (03) :358-417